Changes in the patterns of specific gene expression in response to external stimuli are often executed through the regulation of transcriptional initiation. Extensive research over the past 15 years has indicated that the changes in transcriptional activity are brought about by DNAbinding proteins that recognize regions that flank the structural gene in a sequence-specific manner, and enable efficient recruitment of a complex transcriptional machinery and, ultimately, RNA polymerase (reviewed in [l] ). The external signals function to cause either an increase in the DNA-binding potential of the sequence-specific DNA-binding protein or to increase its ability to recruit the basal transcriptional machinery in some manner. The series of events that connect the external signal with these transcriptional changes is referred to as a signaltransduction pathway. Significantly, most of these pathways act in a 'primary' manner such that no new protein synthesis is required (reviewed in [Z] ). Thus changes in activities of factors are mediated by biochemical events. T o date, most of the pathways of signal transduction have been shown to involve alterations in the phosphorylation state of components. For example, elevated levels of CAMP in response to external stimuli leads to activation of protein kinase A which phosphorylates a sequence-specific DNA-binding Abbreviations used: CREB, CAMP-response-elementbinding protein; CBP, CREB-binding protein; IRF-2, interferon regulatory factor 2; NFKB, nuclear factor KB; ItiB, inhibitor of nuclear factor tiB; SREBP, sterol-regulatory-element-binding proteins; ICE, interleukin-1 /3-converting enzyme.
protein called the CAMP-response-element-binding protein (CREB); once phosphorylated, CREB can interact with an additional protein, CBP, which in turn allows more efficient interaction with the basal transcriptional machinery [3] . However, a different class of covalent modifications of transcription factors has recently emerged, in which the factors or their regulatory partners are proteolytically processed. Here we review some well-defined examples of such cleavages, and discuss our own results on the transcription factor interferon regulatory factor 2 (IRF-2).
Nuclear factor KB (NFKB)
NFKB is a pleiotropic transcription factor that is required for the activation of a large number of immediate immune response genes such as cytokines and attachment molecules (reviewed in [4, 5] subsequent activity of multicatalytic proteasomes [8, 10, 12] . Stimulus-enhanced processing of the 105 kDa precursor of the NFKB subunit p50 also proceeds via a regulated phosphorylation that precedes degradation of the inhibitory C-terminus [6, 13] . By altering amino acids in ItiBa, it has been shown that phosphorylation occurs on two serine residues at the N-terminus (Ser-32 and Ser-36 [14-171); these phosphorylations are required before lysines 21 and 22 can be ubiquitinated [18] , hence the phosphorylation of ItiBa appears to target the molecule for degradation. It also appears that IKBa is phosphorylated and degraded while still associated with NFtiB [9, 10, 19, 20] . A putative ItiBa kinase has been identified by Maniatis and colleagues [21] ; interestingly, this enzyme has a functional requirement for ubiquitination. What is not yet clear is whether there is a unique ItiBa kinase, and how so many diverse signals can converge on such a factor.
Notch
Notch was originally identified in Drosophila melanogaster as a gene that was required for lateral specification, a process whereby a single cell differentiates from amongst a background of equipotent neighbours, as exemplified by the generation of neuroblasts from the ventral ectoderm of the embryo (reviewed in [22] ). A number of homologues have since been identified in other organisms including mammals, where they are also thought to play roles in early developmental events such as myogenesis. Notch is a membrane protein that interacts with a ligand (also a transmembrane protein) on adjacent cells. A productive interaction signals to the Notch-containing cells to suppress differentiation, using a defined transcriptional programme. T h e DNA-binding protein that resides at the 'end point' of the Notch pathway and targets the Notch signal to specific promoters is encoded by the Suppressor of Hairless [24] . This fragment can enter the nucleus and bind directly to Su(H) and lead to transcriptional stimulation [25] . T o date, nothing is known about the nature of the Notch proteases.
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Sterol-regulatory-element-binding proteins (SREBPs)
When cells are deficient in cholesterol levels, a transcriptional programme is initiated that elevates the levels of enzymes required for cholesterol uptake and biosynthesis such as the low-density lipoprotein receptor and hydroxymethylglutaryl-CoA synthase. This programme requires specific elements within the promoters of the genes for these enzymes called sterol regulatory elements, and two SREBPs (SREBP-1 and SREBP-2) have been identified [26, 27] . Surprisingly, these factors are transmembrane proteins that span the endoplasmic reticulum and the nuclear envelope. In response to cholesterol depletion, these proteins are proteolysed and the cytosolic N-terminal portions are released and enter the nucleus to activate transcription [28] . In a recent study of the details of SREBP-2 proteolysis, Sakai et al. [29] have shown that cleavage takes place in two steps; the initial cleavage occurs in the lumen of the endoplasmic reticulum and is dependent on cholesterol depletion, while the subsequent cleavage is sterolindependent and occurs with a transmembrane domain. This second cleavage results in the liberation of the cytoplasmic fragment from the membrane.
The activities of the SREBPs are also regulated by proteolysis in other ways. During apoptosis, these proteins are cleaved by CPP-32 and Mch-3, which are members of the interleukin-1 /3-converting enzyme (ICE)-like protease family [ 30,3 11. These cleavages generate fragments of the SREBPs that can bind to DNA, although their functional significance has not yet been established. Once activated, the nuclear SREBPs are down-regulated in response to cholesterol overload by proteolysis; this process appears to involve proteasomes [28] .
IRF-2
The transcription factor IRF-2 was first identified as a DNA-binding protein that bound to the /)-interferon promoter, and was postulated to function as a repressor of basal level transcrip-tion by excluding the transcriptional activator IRF-1 [32, 33] . However, subsequent gene disruption experiments have shown that IRF-2 appears to be wholly dispensable for basal repression of 1-interferon [34] . Despite this result, IRF-2 may play a role in the turn-off of transcription that occurs late on during viral infection. IRF-2 (apparent molecular mass of 57 kDa) is cleaved during viral infection to leave an N-terminal fragment (IRF-2* of molecular mass 26 kDa) that can still bind to DNA [35-381 (see Figure 1 ). This truncated product has profoundly different properties from full-length IRF-2. Whereas IRF-2 can only bind to DNA in a transient manner, IRF-2* forms stable complexes that have off rates in excess of 90 min [38] , and in transfection experiments IRF-2" is a much stronger repressor of transcription than full-length IRF-2 [38] . Since the strongly repressing IRF-2" begins to be formed at a time when 1-interferon mRNA synthesis is near its peak, and continues to accumulate during the decline in 1-interfercn mRNA levels, it is probable that IRF-2* functions as a post-induction repressor. This model is consistent with the observation that IRF-2-I-knock-out mice show delayed shut off of 1-interferon expression [34] .
In an attempt to map the cleavage site of IRF-2, the electrophoretic mobility of truncated forms of IRF-2 generated in vitro were compared with the in vivo cleavage product (IRF-2*), allowing the cleavage site to be mapped to between amino acids 163 and 181 [38] . A visual inspection of the amino acid sequence in this region for potential cleavage sites revealed the motif Glu-Val-Ala-Asp-Ser between amino acids 168 and 171, a sequence that is similar to the consensus for CPP-32, a member of the ICE family of cysteine proteases (reviewed in [39] ). Protease inhibitors that block activation of N F KB did not inhibit cleavage of IRF-2. However, when cells were treated with the ICE-like protease inhibitor Z-Val-Asp-fluoromethylketone, the generation of IRF-2* was completely blocked. This treatment also caused a prolonged and intensified synthesis of 1-interferon mRNA, consistent with the proposed role for IRF-2". T h e same treatment failed to block the induction of NFKB. T o confirm the role of ICE-like proteases in the production of IRF-2*, we altered the aspartic acid residue at amino acid 170 to an alanine. This altered form of IRF-2 was not cleaved during induction.
An additional function of IRF-2 may be to regulate cell growth [40] . Intriguingly, IRF-2 has been proposed to function as an activator of the histone H4 gene F0108 transcription during the GI-S transition [41] . Since full-length IRF-2 cannot act as an activator of /)-interferon expression [35, 38] , this result suggests that IRF-2 may act as a repressor or activator depending on promoter context. Artificial truncation of mouse IRF-2 demonstrated that removal of the C-terminal 59 amino acids unveiled a strong transactivation domain [42] (see Figure l ) , a result that we have confirmed using human IRF-2. Thus it is possible that transcriptional activation of the histone H4 gene FOl08 utilizes this domain of IRF-2, although it is not clear how the domain would become unmasked. One possibility is post-translational modification; for example, the C-terminus might become modified at the GI-S transition allowing the activation domain to function, and Vaughan et al. [41] have reported the existence of a G,-S-specific factor that is immunologically related to IRF-2. We have failed to Regulation of Transcription and Translation detect an equivalent form of IRF-2 under conditions of p-interferon induction, but recognize that it is possible that a functionally equivalent protein could be generated by proteolysis. We have detected a novel form of IRF-2 in extracts from virally induced cells that has a molecular mass of 40 kDa and includes the N-terminal DNA-binding domain and the transactivation domain (see Figure 1) . Although the precise cleavage site has yet to be determined, we note that IRF-2 has putative ICE-like protease-cleavage sites at amino acids 210 and 242. The 40 kDa truncated product has the potential to be involved in transcriptional activation of the p-interferon gene during viral infection, although it might be expected to be produced with more rapid kinetics than the strongly repressing 26 kDa form of IRF-2 (IRF-2"). We are currently investigating this issue. It has been suggested that ICE-like proteases are activated in a sequential manner (reviewed in [39, 43] ), and it is interesting to speculate that the different cleavage forms of IRF-2 could be generated by temporal differences in activation of distinct proteases.
Conclusion
Several examples are now known where transcription factors alter their function in response to proteolytic cleavage. This review has concentrated on events associated with induced cleavages, but it should be stressed that transcription factor activity can also be regulated by the inhibition of cleavage or degradation. For example, many transcription factors engaged in the regulation of the cell cycle tend to be labile, and are often degraded through the ubiquitin-proteasome pathway [44] ; it is interesting to speculate that stabilization may be a commonly occurring event that leads to oncogenesis. This is exemplified by the transcription factors p53 and c-Jun. p53 is normally turned over rapidly, but becomes stabilized in response to DNA damage; this event contributes to cell-cycle arrest at the GI-S transition. T h e turnover of p53 normally involves the ubiquitin-proteasome pathway [45] , although it is not clear how this activity is regulated by DNA damage. T h e human papilloma virus oncoprotein E6 plays a role in negating cell-cycle arrest by targeting p53 to a specific ubiquitin-conjugating enzyme, leading to its rapid degradation [46-481. T h e activating protein 1 component c-Jun is also normally turned over rapidly using a mechanism that seems to depend on the ubiquitin-proteasome pathway [49] ; the specific target for this pathway resides within a small region of the protein called the 6 domain, and this peptide is deleted in the oncogenic v-Jun protein leading to stabilization of the protein.
It is clear from the above that many proteins are degraded by proteasome-dependent events, and in many cases the rate of degradation is altered in response to environmental signals (such as cholesterol-overload-induced degradation of the SREBPs or ligand-induced degradation of Ih-Ba). It is not at all clear how proteasome activity can be regulated, and this promises to be one of the key questions in the area of cellular regulation. It is also apparent that the ICE-like proteases can target transcription factors and alter their properties, in some cases leading to activation. Although the activities of the ICE-like proteases have shown themselves to be tightly regulated in that they respond to changes in cellular environmental stress (reviewed in [43] ), it is not yet known whether these proteases can be regulated by nonapoptotic signals. The ligand-induced cleavages of the SREBPs and Notch comprise a third class of proteolysis in that they do not appear to involve proteasomes or ICE-like proteases. It remains to be seen how common the regulation of transcription factor activity by proteolysis is, but the increasing number of examples suggests that it comprises a major class of regulatory events.
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